Article Data

  • Views 681
  • Dowloads 150

Original Research

Open Access

Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?

  • Fengmei Wang1,†
  • Huachun Luo2,†
  • Huihua Cheng2
  • Huijuan Huang1
  • Zhichao Fu2,*,

1Department of Obstetrics and Gynecology, Fuzhou General Hospital of PLA (Xiamen Dongfang Hospital), Fuzhou, Fujian Province, P. R. China

2Department of Radiation Oncology, Fuzhou General Hospital of PLA (Xiamen Dongfang Hospital), Fuzhou, Fujian Province, P. R. China

DOI: 10.31083/j.ejgo.2020.04.4932 Vol.41,Issue 4,August 2020 pp.591-597

Submitted: 10 July 2018 Accepted: 30 October 2018

Published: 15 August 2020

*Corresponding Author(s): Zhichao Fu E-mail: fauster1112@126.com

† These authors contributed equally.

Abstract

Objective: To investigate the guidance value of 3D printing in brachytherapy for cervical cancer and its role in the doctor-patient communication. Results: The median follow-up time was 36 months (10-63); 3D models of 50 patients with cervical cancer were successfully printed out. Fifty patients underwent 255 times the source applicator. EQD 2 of HR-CTV D90, bladder D2cc, sigmoid colon D2cc, and rectal D2cc were 75.26 ± 6.31, 67.84 ± 8.75, 47.36 ± 7.62, and 62.45 ± 8.68 Gy, respectively, and the overall score of the verisimilitude and usefulness of 3D printing models by five doctors was 8.0 ± 0.8 points. The score of patients’ satisfaction to the use of 3D printing model for operation communication was 9.0 ± 0.5 points. During three months of follow-up, two patients were with rectal hemorrhage in later period (level 2), and the symptoms were improved after hemostasis, enema and other symptomatic treatments. Three-year local control (LC) was 92% (46/50), three-year progression-free survival (PFS) was 82% (41/50), and three-year overall survival (OS) was 84%. Three-year late toxic and side effects mainly include radiation proctitis, radiation urethritis, and vaginitis, and their level 3 incidence rates were: radiation gastroenteritis 10%, radiation urethritis 6%, and radiation vaginitis l: 8%, respectively. Conclusion: 3D printing model can well display relationship with the surrounding normal tissues and effectively guide doctors to conduct individualized brachytherapy for cervical cancer. It can also be used as a tool to communicate with patients, render doctor-patient communication more effective, and obtain a good curative effect and less toxic and adverse effects, which is worth further clinical practice.

Keywords

3D-printing; Cervical cancer; Brachytherapy

Cite and Share

Fengmei Wang,Huachun Luo,Huihua Cheng,Huijuan Huang, Zhichao Fu. Is 3D printing-gided three-dimensional brachytherapy suitable for cervical cancer: from one single research institute?. European Journal of Gynaecological Oncology. 2020. 41(4);591-597.

References

[1] Elit L., Fyles A.W., Devries M.C., Oliver T.K., Fung­Kee­Fung M.: “Follow­up for women after treatment for cervical cancer: a system­atic review”. Gynecol. Oncol., 2009, 114, 528.

[2] Krishnamurthy. S., Pathy. S., Ahmed. .I, Chander. S.: “Comments on vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy”. Radiother. Oncol., 2014, 113, 426.

[3] Mohamed. S., Kallehauge. J., Fokdal. L., Lindegaard. J.C., Tanderup. K.: “Parametrial boosting in locally advanced cer­ vical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy”. Brachytherapy, 2015, 14, 23.

[4] Tharavichitkul. E., Wanwilairat. S., Chakrabandhu. S., Klunklin, P., Onchan. W., Tippanya. D., Nopnop. W., et al.: “Image­guided brachytherapy (IGBT) combined with whole pelvic intensity­ modulated radiotherapy (WP­IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital“, Thailand. J. Contemp. Brachytherapy, 2013, 5, 10. [5] Tanderup. K. V., Kirisits. C. F.,: “Magnetic resonance image guided brachyther­ apy“. Semin. Radiat. Oncol,. 2014, 24, 181.

[5] Murakami. N., Kasamatsu. T., Wakita. A, Nakamura. S., Okamoto. H., Inaba. K., et al.: “CT based three dimensional dose­volume eval­ uations for high­dose rate intracavitary brachytherapy for cervical cancer“. BMC. Cancer, 2014, 14, 447.

[6] Mesko. S., Swamy. U., Park. S.J., Borja. L., Wang. J., De­ manse.D.J., et al.: “Early clinical outcomes of ultrasound­guided CT­planned high­dose­rate interstitial brachytherapy for primary lo­cally advanced cervical cancer“. Brachytherapy, 2015, 14, 626.

[7] Castelnau. Marchand. P., Chargari. C., Haie.­Meder. C., Mazeron. R.: “Image­guided adaptive brachytherapy in locally advanced cer­ vical cancer: recent advances and perspectives“. Curr. Opin. Oncol., 2016, 28, 419.

[8] AbouHashem. Y., Dayal. M., Savanah. S., Štrkalj.: “The application of 3D printing in anatomy education“. Med. Educ. Online, 2015, 20, 29847.

[9] Knowlton. S., Yenilmez. B., Tasoglu. S.: “Towards Single­Step Bio­ fabrication of Organs on a Chip via 3D Printing“. Trends Biotech­ nol., 2016, 34, 685.

[10] Canters. R. A., Lips. I. M., Wendling. M., Kusters. M., van. Zeeland. M., Gerrisen. R.M., et al.: “Clinical implementation of 3D printing in the construction of patient specific bolus for electron beam radio­ therapy for non­melanoma skin cancer“. Radiother. Oncol., 2016, 121, 148.

[11] Lieben. L.: “Regenerative medicine: The future of 3D printing of human tissues is taking shape“. Nat. Rev. Rheumatol., 2016, 12, 191.

[12] Michalski. M. H., Ross. J. S.: “The shape of things to come: 3D printing in medicine“. JAMA, 2014, 312, 2213.

[13] Lee. S., Kang. B., Keum. H., Ahmed. N., Roqers. J.A., Ferreira. P. M., et al.: “Heterogeneously Assembled Metamaterials and Metade­ vices via 3D Modular Transfer Printing“. Sci. Rep., 2016, 6, 27621.

[14] Oshiro. Y, Mitani. J, Okada T., Ohkohchi. N.,: “A novel three­dimensional print of liver vessels and tumors in epatec­ tomy“.Surg.Today, 2017, 47, 521. [16] Emodi. O., Shilo. D., Is­ rael. Y., Rachmiel. A.: “Three­dimensional planning and printing of guides and templates for reconstruction of the mandibular ramus and condyle using autogenous costochondral grafts“. Br. J. Oral. Maxillofac. Surg., 2017, 55, 102.

[15] Oh. D., Huh S.J., Park W., Ju S.G., Nam H., Lee J.E,: “Clinical out­ comes in cervical cancer patients treated by FDG­PET/CT­based 3­ dimensional planning for the first brachytherapy session“. Medicine (Baltimore), 2016, 95, e3895. [18] Kong. X., Nie. L., Zhang. H., Wang. Z., Ye. Q., Tang. L., et al.: “Do 3D Printing Models Im­ prove Anatomical Teaching About Hepatic Segments to Medical Students? A Randomized Controlled Study“. World. J. Surg, 2016, 40, 1969.

[16] Marconi. D. G., Fregnani. J. H. T. T., Rossini. R. R., Netto. A. K. B. J., Lucchesi. R. R., Tsunoda. A. T., et al.: “Pre­treatment MRI min­ imum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation”. B. M. C. Cancer., 2016, 16, 556.

[17] Soliman. A. S., Elzibak. A., Easton. H., Kim. J. Y., Han. D. Y., Safiqholi. H., et al.: “Quantitative MRI assessment of a novel direc­ tion modulated brachytherapy tandem applicator for cervical cancer at 1.5T“. Radiother. Oncol., 2016, 120, 500

[18] Madan. R., Pathy. S., Subramani. V., Sharma. S., Mohanti. B.K., Chander. S., et al.: “Comparative evaluation of two­dimensional ra­ diography and three dimensional computed tomography based dose­ volume parameters for high­dose­rate intracavitary brachytherapy of cervical cancer: a prospective study“. Asian. Pac. J. Cancer. Prev., 2014, 15, 4717.

[19] Marosevic. G., Ljuca. D., Osmic. H., Fazlic. S., Arsovski. O., Mileusnic. D.: “Inter­application displacement of brachytherapy dose received by the bladder and rectum of the patients with inop­ erable cervical cancer“. Radiol. Oncol., 2014, 48, 203.

[20] Mitsouras. D., Lee. T. C., Liacouras. P., Lonita. C. N., Pietilla. T., Maier. S. E., et al.: “Three­-dimensional printing of MRI­visible phantoms and MR image­guided therapy simulation. Magn. Reson. Med., 2017, 777, 613.

[21] Radenkovic. D., Solouk. A., Seifalian. A.: “Personalized develop­ ment of human organs using 3D printing technology“. Med. Hy­ potheses., 2016, 87, 30.

[22] Canabrava. S., Diniz­Filho. A., Schor. P., Fagundes. D.F., Lopes. A., Batista. W. D.: “Production of an intraocular device using 3D printing: an innovative technology for ophthalmology“. Arq. Bras. Oftalmol, 2015, 78, 393.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top